Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients

These results suggest that long-term rHuEPO therapy can correct fibrinolytic parameters in patients undergoing regular HD irrespective from haemoglobin levels and in the absence of concomitant iron supplementation.